Élie Besserer-Offroy, Ph.D.

Affiliations: 
2010-2018 Department of Pharmacology - Physiology Université de Sherbrooke, Sherbrooke, Québec, Canada 
 2018-2021 Department of Pharmacology and Therapeutics McGill University, Montreal, QC, Canada 
 2021-2023 Department of Molecular and Medical Pharmacology University of California, Los Angeles, Los Angeles, CA 
 2023- UFR Santé / Inserm UMR-S 1086 Anticipe Université de caen 
Google:
"Élie Besserer-Offroy"
Mean distance: 106866
 

Parents

Sign in to add mentor
Philippe Sarret grad student 2010-2018 Université de Sherbrooke
Terence E. Hebert post-doc 2018-2021 McGill (Chemistry Tree)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Pétigny C, Dumont AA, Giguère H, et al. (2022) Monitoring TRPC7 Conformational Changes by BRET Following GPCR Activation. International Journal of Molecular Sciences. 23
Tran K, Sainsily X, Côté J, et al. (2022) Size-Reduced Macrocyclic Analogues of [Pyr]-apelin-13 Showing Negative Gα Bias Still Produce Prolonged Cardiac Effects. Journal of Medicinal Chemistry. 65: 531-551
Michaelian N, Sadybekov A, Besserer-Offroy É, et al. (2021) Structural insights on ligand recognition at the human leukotriene B4 receptor 1. Nature Communications. 12: 2971
Vivancos M, Fanelli R, Besserer-Offroy É, et al. (2021) Metabolically Stable Neurotensin Analogs Exert Potent and Long-Acting Analgesia Without Hypothermia. Behavioural Brain Research. 113189
Besserer-Offroy É, Brouillette RL, Longpré JM, et al. (2020) Assessing Gα-signaling with IP-One: Single Plate Transfection and Assay Protocol for Cell-Based High-Throughput Assay. Bio-Protocol. 10: e3715
Sadybekov AA, Brouillette RL, Marin E, et al. (2020) Structure-Based Virtual Screening of Ultra-Large Library Yields Potent Antagonists for a Lipid GPCR. Biomolecules. 10
Besserer-Offroy É, Tétreault P, Brouillette RL, et al. (2020) Data set describing the biological activity of JMV2009, a novel silylated neurotensin(8-13) analog. Data in Brief. 31: 105884
Tétreault P, Besserer-Offroy É, Brouillette RL, et al. (2020) Pain relief devoid of opioid side effects following central action of a silylated neurotensin analog. European Journal of Pharmacology. 173174
Brouillette RL, Besserer-Offroy É, Mona CE, et al. (2020) Cell-penetrating pepducins targeting the neurotensin receptor type 1 relieve pain. Pharmacological Research. 104750
Gusach A, Luginina A, Marin E, et al. (2019) Structural basis of ligand selectivity and disease mutations in cysteinyl leukotriene receptors. Nature Communications. 10: 5573
See more...